Showing results (1-10 of 2,929) with videos related to

Sort By:
Pageof 293
Biorxiv : the Preprint Server for Biology|January 23, 2026
Haruka Resolves Perturbation Response Heterogeneity in Spatial Cell NichesYan Cui, Jasmine Blandin, Kipp Weiskopf, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2017
Cancer immunotherapy targeting the CD47/SIRPα axisKipp Weiskopf
Biorxiv : the Preprint Server for Biology|November 28, 2024
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphomaJuliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
Mabs|February 11, 2015
Macrophages are critical effectors of antibody therapies for cancerKipp Weiskopf, Irving L Weissman
Expert Opinion on Investigational Drugs|March 11, 2026
Targeting the CD47/SIRP⍺Interaction in cancer: opportunities in Non-Hodgkin LymphomaCarlota Pagès-Geli, Kipp Weiskopf
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2016
Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodiesJames Torchia, Kipp Weiskopf, Ronald Levy
The Journal of Clinical Investigation|March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destructionKyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
CD47 predominates over CD24 as a macrophage immune checkpoint in cancerJuliet Allen, Anna Meglan, Kyle Vaccaro, et al.
Oncoimmunology|November 22, 2012
Flipping the script on macrophages in leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Irving L Weissman, et al.
Pageof 293